CRISPR Edited Knockdown of CCL5 Enhances Antitumor Immune Responses
Posted by Mike Dwinell on 3/28/2025 to
Recent Publications
CRISPR edited knockdown of CCL5 enhances antitumor immune responses
CCL5, originally called RANTES (Regulated upon